Plaque Psoriasis 
The MD Magazine Plaque Psoriasis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Most Patients with Plaque Psoriasis Are Dissatisfied with Their Treatment
Many psoriasis patients wish they were better informed of the significant impact their skin condition would have on their physical and mental health, according to results from Psoriasis in America 2016, a Health Union national survey.
This most recent trial of the investigational agent E6005 follows on a previous study that evidenced benefit in adult patients.
Whether applied to skin that is presoaked or dry, there is no difference in the effectiveness of topical corticosteroids in treating atopic dermatitis, according to a new controlled comparison study in children.
For millions of Americans, including as many as one in four children, the painful skin irritation of atopic dermatitis (AD, or eczema), may only be the tip of the iceberg.
The FDA has approved UltraShape Power (Syneron Medical Ltd) for non-invasive reduction of abdominal circumference through fat cell destruction.
The US Food and Drug Administration's (FDA's) Arthritis Advisory Committee recently voted unanimously to recommend the approval of biosimilars to adalimumab (Humira) and etanercept (Enbrel).
A new study found that female psoriasis patients have a fourfold increased risk of developing Crohn’s disease (CD).
A family history of heart attacks increases psoriasis patients’ odds of having heart attacks and strokes.
Novartis conducted a global survey of 8,338 patients with moderate-to-severe psoriasis across 31 countries to assess patients’ perceptions of what constitutes “clear skin.”

Most Popular


$vacMongoViewPlus$ $vAR$